JP2014024874A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014024874A5 JP2014024874A5 JP2013231673A JP2013231673A JP2014024874A5 JP 2014024874 A5 JP2014024874 A5 JP 2014024874A5 JP 2013231673 A JP2013231673 A JP 2013231673A JP 2013231673 A JP2013231673 A JP 2013231673A JP 2014024874 A5 JP2014024874 A5 JP 2014024874A5
- Authority
- JP
- Japan
- Prior art keywords
- tableting
- dissolution
- improving
- composition
- magnesium stearate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Claims (3)
- 組成物を圧縮する打錠工程を含むことを特徴とするオルメサルタンメドキソミル含有錠剤の溶出性改善方法であって、前記打錠工程が、141-400 N/mm 2 の圧力を使用する工程かつ、ステアリン酸マグネシウムを除く成分を混合した後にステアリン酸マグネシウムを加えて混合した組成物を打錠する工程であり、前記溶出率改善が、日本薬局方第14改正の項に記載されている溶出試験法第2法(パドル法)による30分後溶出率結果を打錠用混合末に対して20%以上増加させるものである溶出率改善方法。
- 組成物を圧縮する打錠工程を含むことを特徴とするオルメサルタンメドキソミル含有錠剤(但し、結晶セルロース又はトウモロコシデンプンを含有する錠剤を除く)の溶出性改善方法であって、前記打錠工程が、60-400 N/mm2の圧力を使用する工程であり、ステアリン酸マグネシウムを除く成分を混合した後にステアリン酸マグネシウムを加えて混合した組成物を打錠する工程である方法。
- 組成物が、溶出改善剤を含む請求項1又は請求項2のいずれかに記載の溶出性改善方法。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2013231673A JP2014024874A (ja) | 2006-06-27 | 2013-11-08 | 圧縮製剤 |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2006176146 | 2006-06-27 | ||
JP2006176146 | 2006-06-27 | ||
JP2013231673A JP2014024874A (ja) | 2006-06-27 | 2013-11-08 | 圧縮製剤 |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2008522575A Division JP5769362B2 (ja) | 2006-06-27 | 2007-06-26 | 圧縮製剤 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2014024874A JP2014024874A (ja) | 2014-02-06 |
JP2014024874A5 true JP2014024874A5 (ja) | 2014-08-07 |
Family
ID=38845498
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2008522575A Active JP5769362B2 (ja) | 2006-06-27 | 2007-06-26 | 圧縮製剤 |
JP2013231673A Pending JP2014024874A (ja) | 2006-06-27 | 2013-11-08 | 圧縮製剤 |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2008522575A Active JP5769362B2 (ja) | 2006-06-27 | 2007-06-26 | 圧縮製剤 |
Country Status (9)
Country | Link |
---|---|
US (1) | US20100237530A1 (ja) |
EP (1) | EP2033643A4 (ja) |
JP (2) | JP5769362B2 (ja) |
KR (1) | KR101628028B1 (ja) |
CN (1) | CN101478966B (ja) |
BR (1) | BRPI0713371A2 (ja) |
CA (1) | CA2656181C (ja) |
TW (1) | TWI492747B (ja) |
WO (1) | WO2008001734A1 (ja) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5554699B2 (ja) * | 2008-03-13 | 2014-07-23 | 第一三共株式会社 | オルメサルタンメドキソミルを含む製剤の溶出性の改善 |
JP2011136908A (ja) * | 2009-12-25 | 2011-07-14 | Kyowa Yakuhin Kogyo Kk | アンギオテンシンii受容体拮抗剤を含む固形製剤および固形製剤におけるアンギオテンシンii受容体拮抗剤の保存安定性向上方法 |
CN102119930B (zh) * | 2010-07-13 | 2013-01-30 | 福建天泉药业股份有限公司 | 一种奥美沙坦酯片及制备方法 |
EP2425859A1 (en) | 2010-08-08 | 2012-03-07 | Abdi Ibrahim Ilac Sanayi ve Ticaret Anonim Sirketi | Olmesartan formulations |
CN102028663B (zh) * | 2010-12-14 | 2011-11-30 | 北京万生药业有限责任公司 | 一种稳定的奥美沙坦酯固体制剂 |
DK2830618T3 (en) * | 2012-03-30 | 2016-10-03 | Dae Woong Pharma | A pharmaceutical composition comprising olmesartan medoxomil and rosuvastatin or its salt |
CN105663070A (zh) * | 2014-11-21 | 2016-06-15 | 深圳信立泰药业股份有限公司 | 一种含有奥美沙坦酯的药物组合物及其制备方法 |
CN105640913B (zh) * | 2016-01-22 | 2018-11-02 | 山东省医学科学院药物研究所 | 一种奥美沙坦酯片及其制备方法 |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3096248A (en) * | 1959-04-06 | 1963-07-02 | Rexall Drug & Chemical Company | Method of making an encapsulated tablet |
JPH0282519A (ja) | 1988-09-19 | 1990-03-23 | Sanyo Electric Co Ltd | 固相エピタキシャル成長方法 |
US5616599A (en) * | 1991-02-21 | 1997-04-01 | Sankyo Company, Limited | Angiotensin II antagosist 1-biphenylmethylimidazole compounds and their therapeutic use |
JPH0624959A (ja) * | 1991-10-04 | 1994-02-01 | Bayer Yakuhin Kk | 胃内浮遊型薬物徐放性固形製剤 |
US5298261A (en) * | 1992-04-20 | 1994-03-29 | Oregon Freeze Dry, Inc. | Rapidly distintegrating tablet |
US6465009B1 (en) * | 1998-03-18 | 2002-10-15 | Yamanouchi Pharmaceutical Co., Ltd. | Water soluble polymer-based rapidly dissolving tablets and production processes thereof |
DE69928110T2 (de) * | 1998-07-15 | 2006-07-27 | Asahi Kasei Chemicals Corporation | Trägerhilfstoff |
JP3796562B2 (ja) * | 1999-05-26 | 2006-07-12 | ライオン株式会社 | 多層錠、多層錠の製造方法及び多層錠の剥離抑制方法 |
BR0112124B1 (pt) * | 2000-07-05 | 2011-06-14 | pà de celulose, processo para produzir um pà de celulose, excipiente, e, produto moldado. | |
JP2002167327A (ja) * | 2000-09-22 | 2002-06-11 | Takeda Chem Ind Ltd | 固形製剤 |
US20040132731A1 (en) * | 2002-06-26 | 2004-07-08 | Fox David Nathan Abraham | Novel combination |
NZ541454A (en) * | 2003-01-31 | 2008-04-30 | Daiichi Sankyo Co Ltd | Medicine for prevention of and treatment for arteriosclerosis and hypertension |
CA2532450C (en) | 2003-07-16 | 2012-09-11 | Boehringer Ingelheim International Gmbh | Chlorthalidone combinations |
ES2688193T3 (es) * | 2003-10-15 | 2018-10-31 | Fuji Chemical Industry Co., Ltd. | Comprimido de disgregación rápida en la cavidad oral |
GB0325291D0 (en) * | 2003-10-29 | 2003-12-03 | Pfizer Ltd | Novel combination |
AU2004285354B2 (en) * | 2003-10-31 | 2009-09-17 | Takeda Pharmaceutical Company Limited | Solid preparation comprising an insulin sensitizer, an insulin secretagogue and a polyoxyethylene sorbitan fatty acid ester |
CA2575177A1 (en) | 2004-09-02 | 2006-03-16 | Teva Pharmaceutical Industries Ltd. | Purification of olmesartan medoxomil |
WO2007001067A2 (en) * | 2005-06-27 | 2007-01-04 | Daiichi Sankyo Company, Limited | Solid dosage form comprising an angiotensin ii receptor antagonist and a calcium channel blocker |
US20080279942A1 (en) | 2005-06-27 | 2008-11-13 | Takeshi Hamaura | Pharmaceutical Preparation Containing an Angiotensin II Receptor Antagonist and a Calcium Channel Blocker |
JP5063370B2 (ja) * | 2005-06-27 | 2012-10-31 | 第一三共株式会社 | 湿式造粒製薬の調製方法 |
EP1891952B1 (en) | 2006-05-04 | 2011-10-05 | LEK Pharmaceuticals d.d. | Pharmaceutical composition of olmesartan medoxomil |
-
2007
- 2007-06-26 KR KR1020087031327A patent/KR101628028B1/ko active IP Right Grant
- 2007-06-26 BR BRPI0713371-5A patent/BRPI0713371A2/pt not_active Application Discontinuation
- 2007-06-26 WO PCT/JP2007/062734 patent/WO2008001734A1/ja active Application Filing
- 2007-06-26 US US12/305,705 patent/US20100237530A1/en not_active Abandoned
- 2007-06-26 CA CA2656181A patent/CA2656181C/en not_active Expired - Fee Related
- 2007-06-26 CN CN2007800236173A patent/CN101478966B/zh active Active
- 2007-06-26 EP EP20070767540 patent/EP2033643A4/en not_active Withdrawn
- 2007-06-26 JP JP2008522575A patent/JP5769362B2/ja active Active
- 2007-06-26 TW TW096122976A patent/TWI492747B/zh active
-
2013
- 2013-11-08 JP JP2013231673A patent/JP2014024874A/ja active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2014024874A5 (ja) | ||
JP2014167026A5 (ja) | ||
CL2013001586A1 (es) | Composicion microgranular de rapida dispersion que comprende al menos un alcohol de azucar, un sacarido, o una mezcla de estos, al menos un super disgregante y al menos un aditivo multifuncion; comprimido de desintegracion oral que comprende la composicion microgranular y al menos un principio activo; y metodos de fabricacion. | |
EP2600849A4 (en) | COMPOSITION FORMING A FILM FOR SOFT CAPSULES | |
JP2015511635A5 (ja) | ||
JP2017520577A5 (ja) | ||
WO2011104652A3 (en) | Veterinary compositions | |
AU2014271645B2 (en) | Oral cavity patch | |
JP2009542678A5 (ja) | ||
JP2016108327A5 (ja) | ||
WO2008100240A3 (en) | Pharmaceutical composition with sodium lauryl sulfate as an extra-granular absorption/compression enhancer and the process to make the same | |
RU2016117186A (ru) | Комбинированная композиция, содержащая тадалафил и амлодипин | |
HRP20141134T1 (hr) | Kruta farmaceutska formulacija | |
JP2015129124A5 (ja) | ||
JP2014218523A5 (ja) | ||
JP2009091362A5 (ja) | ||
TW200732000A (en) | Orally disintegrating table comprising fat-soluble drug | |
JP2017520619A5 (ja) | ||
JP2016535762A5 (ja) | ||
CN103860508A (zh) | 一种盐酸二甲双胍缓释片及其制备方法 | |
RU2018100755A (ru) | Комбинированный препарат мозаприда и рабепразола | |
CN103908435B (zh) | 一种氟他胺缓释制剂及其制备方法 | |
WO2011151018A3 (en) | Orodispersible tablets of erythritol and isomalt | |
CN105106963B (zh) | 马来酸曲美布汀缓释制剂及其制备方法 | |
CN101461815B (zh) | 三氟柳药物组合物及其制备方法 |